Category Archives: Chantix

Featured Stories

Actos, Avandia May Up Risk for Diabetic Macular Edema

A newly published study is raising concerns that patients who take Actos or Avandia may face an increased risk of developing diabetic macular edema, an eye disorder that can result in vision loss. The study, published in the Archives of Internal Medicine, found that type 2 diabetics who use thiazolidinediones, ...

Read More

Scientist Calls for Federal Regulations for Fracking Pollution

Hydraulic fracturing (fracking) drilling should be governed by federal regulations because its pollution has no awareness of state boundaries.

Read More

Fracking Releasing Hazardous Chemicals into Local Waterways

Fracking Releasing Hazardous Chemicals into Local Waterways

Study shows two hazardous chemicals—ammonium & iodide—are being released & spilled into Pennsylvania and W.Virginia waterways from fracking operations in Marcellus shale.

Read More

Image Source: wisegeek.com

Trial over Ethicon Transvaginal Mesh Begins in California

Pelvic mesh devices have become the subject of safety concerns in recent years amidst reports that they can cause serious, sometimes permanent injuries.

Read More

Hip Replacement, Knee Implant Patients with Diabetes, Other Health Problems May Face Difficult Recoveries

Patients receiving hip replacement devices or knee implants may face a more complicated recovery if they are obese, or suffer from diabetes or other health woes. According to a new study published online in the journal Anesthesiology, at least 3% of all total hip or knee replacement patients will ...

Read More

Federal Judge Certifies Medtronic Infuse Shareholder Class Action Lawsuit

A shareholder lawsuit alleging Medtronic Inc. illegally promoted the off-label use of its Infuse bone growth product has been granted class action status by U.S. District Judge Paul Magnuson of Minnesota. According to a report from Law360.com, the Medtronic Infuse off-label promotion lawsuit was filed by several institutional investors on ...

Read More

National Law Firms Calls for More FDA Action on Actos Bladder Cancer Threat

A national law firm is not satisfied with the way the U.S. Food & Drug Administration (FDA) has handled warnings regarding Actos (pioglitazone) bladder cancer risks. In a statement published today, Parker Waichman LLP called on the FDA to compel Takeda Pharmaceuticals, the maker of the type 2 diabetes drug, ...

Read More

Another Metal-on-Metal Hip Replacement Lawsuit Filed in DePuy ASR Hip Implant Litigation

A vital food safety program was saved from budget cuts this week, enabling the country’s largest—although considered by experts to be far too small—produce-safety testing program to continue.

Read More

Former Executives Accuse Health Technology Firm of Fraud

Former Executives Accuse Health Technology Firm of Fraud

Former NantHealth executives claim that the company made fraudulent claims about the reliability of its system, which links patient information gathered by the devices.

Read More

FDA Scrutinizes Pfizer Study Evaluating Chantix Suicide Risks

FDA Scrutinizes Pfizer Study Detailing Chantix Suicide Risks

The U.S. Food and Drug Administration (FDA) is questioning whether or not Pfizer’s study of neuropsychiatric effects of Chantix, the smoking cessation drug, accurately reflects the risks. Pfizer conducted the clinical trial upon request from the FDA, following a high … Continue reading

Posted in Chantix, Pharmaceuticals | Tagged , , , , , , , |

Expert Witness in Chantix Case Seeks Pfizer Documents

An expert witness in the multidistrict litigation over Chantix (varenicline), a smoking cessation drug, has moved to unseal court records in advance of a Food and Drug Administration (FDA) meeting to consider whether the drug should carry a warning about … Continue reading

Posted in Chantix, Pharmaceuticals |

FDA to Convene Panel on Smoking Cessation Drug, Chantix, Over Psychiatric, Behavioral Side Effect Risks

The U.S. Food and Drug Administration (FDA) announced that it plans to review Chantix, the smoking cessation drug, to determine if its quit smoking benefits exceed its psychiatric and behavioral risks, Approved in 2006, Chantix received the U.S. Food and … Continue reading

Posted in Chantix, Pharmaceuticals |

Motion denied to delay Chantix trial

The first trial alleging the stop-smoking drug Chantix causes serious and some life-threatening side effects will go forward as scheduled after a federal court judge denied a request by the drug’s maker to delay it in light of a new … Continue reading

Posted in Chantix, Health Concerns, Pharmaceuticals | Tagged |

BPA Side Effects May Be Long Lasting

A recent study suggests that the side effects of BPA may be long lasting. BPA, or bisphonel A, a controversial plastics chemical, has been linked to a growing and broad array of adverse health effects. In this study, the effects … Continue reading

Posted in Chantix, Legal News, Radiation Exposure Environmental Contamination |

U. Of Penn Researchers Testing Chantix Despite Risks

Despite its known risks, University of Pennsylvania researchers plan on testing the smoking cessation medication, Chantix (varenicline). The U.S. Food & Drug Administration (FDA) approved Chantix in 2006. Chantix blocks nicotine by targeting the brain’s nicotine receptors; however, about a … Continue reading

Posted in Chantix, Health Concerns, Pharmaceuticals |

Study Finds Chantix Linked to Suicidal Behavior, Depression More Frequently than Other Stop-Smoking Treatments

A team of researchers is calling on the U.S. Food & Drug Administration (FDA) to beef up warnings for < "http://www.yourlawyer.com/topics/overview/chantix_side_effects">Chantix (varenicline), after their study found the drug’s psychological side effects make it unsuitable for first-line use as a smoking-cessation … Continue reading

Posted in Chantix, Pharmaceuticals |

FDA Modifies Chantix Label for Heart, COPD Patients

The < "http://www.yourlawyer.com/topics/overview/chantix_side_effects">Chantix label has been updated with new information regarding the safety and efficacy of the smoking cessation medication, according to an announcement from the U.S. Food & Drug Administration (FDA). The modifications to the Chantix label apply to … Continue reading

Posted in Chantix, Pharmaceuticals |

Chantix Study Sees Significant Increase in Heart Risks

People taking < "http://www.yourlawyer.com/topics/overview/chantix_side_effects">Chantix (varenicline), Pfizer Inc.’s controversial stop-smoking drug, face a much higher risk of heart attacks, strokes and other serious cardiovascular events, according to a new study from researchers at Johns Hopkins University and Wake Forest Baptist Medical … Continue reading

Posted in Chantix, Pharmaceuticals |

Health Canada Reviewing Champix for Heart Side Effects

Health Canada is reviewing the smoking cessation drug Champix (sold as < "http://www.yourlawyer.com/topics/overview/chantix_side_effects">Chantix is the U.S.) for a possible link to heart problems. The Health Canada announcement follows last week’s notification by the U.S. Food & Drug Administration (FDA) that … Continue reading

Posted in Chantix, Pharmaceuticals |

© 2005-2019 Parker Waichman LLP ®. All Rights Reserved.